nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naltrexone—UGT1A1—lung cancer	0.00834	0.295	CrCbGaD
Nalbuphine—Morphine—UGT1A1—lung cancer	0.00514	0.182	CrCbGaD
Nalbuphine—Buprenorphine—CYP2A6—lung cancer	0.00385	0.136	CrCbGaD
Nalbuphine—Buprenorphine—ABCG2—lung cancer	0.00344	0.122	CrCbGaD
Nalbuphine—Naltrexone—ABCB1—lung cancer	0.00195	0.069	CrCbGaD
Nalbuphine—Feeling abnormal—Vinorelbine—lung cancer	0.00167	0.00184	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—lung cancer	0.00166	0.00184	CcSEcCtD
Nalbuphine—Pruritus—Erlotinib—lung cancer	0.00166	0.00183	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vinorelbine—lung cancer	0.00165	0.00182	CcSEcCtD
Nalbuphine—Shock—Irinotecan—lung cancer	0.00164	0.00181	CcSEcCtD
Nalbuphine—Tension—Paclitaxel—lung cancer	0.00164	0.0018	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—lung cancer	0.00163	0.0018	CcSEcCtD
Nalbuphine—Dysgeusia—Paclitaxel—lung cancer	0.00163	0.0018	CcSEcCtD
Nalbuphine—Oedema—Gemcitabine—lung cancer	0.00162	0.00179	CcSEcCtD
Nalbuphine—Nervousness—Paclitaxel—lung cancer	0.00162	0.00179	CcSEcCtD
Nalbuphine—Hypoaesthesia—Docetaxel—lung cancer	0.00161	0.00178	CcSEcCtD
Nalbuphine—Hyperhidrosis—Irinotecan—lung cancer	0.00161	0.00178	CcSEcCtD
Nalbuphine—Dizziness—Vinblastine—lung cancer	0.00161	0.00178	CcSEcCtD
Nalbuphine—Convulsion—Cisplatin—lung cancer	0.00161	0.00177	CcSEcCtD
Nalbuphine—Urticaria—Vinorelbine—lung cancer	0.00161	0.00177	CcSEcCtD
Nalbuphine—Muscle spasms—Paclitaxel—lung cancer	0.0016	0.00177	CcSEcCtD
Nalbuphine—Body temperature increased—Vinorelbine—lung cancer	0.0016	0.00176	CcSEcCtD
Nalbuphine—Abdominal pain—Vinorelbine—lung cancer	0.0016	0.00176	CcSEcCtD
Nalbuphine—Anxiety—Cisplatin—lung cancer	0.00157	0.00174	CcSEcCtD
Nalbuphine—Vision blurred—Paclitaxel—lung cancer	0.00157	0.00173	CcSEcCtD
Nalbuphine—Hyperhidrosis—Gemcitabine—lung cancer	0.00157	0.00173	CcSEcCtD
Nalbuphine—Dizziness—Topotecan—lung cancer	0.00156	0.00173	CcSEcCtD
Nalbuphine—Tremor—Paclitaxel—lung cancer	0.00156	0.00172	CcSEcCtD
Nalbuphine—Hypotension—Irinotecan—lung cancer	0.00156	0.00172	CcSEcCtD
Nalbuphine—Vomiting—Vinblastine—lung cancer	0.00155	0.00171	CcSEcCtD
Nalbuphine—Dizziness—Erlotinib—lung cancer	0.00155	0.00171	CcSEcCtD
Nalbuphine—Agitation—Paclitaxel—lung cancer	0.00153	0.00169	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—lung cancer	0.00153	0.00169	CcSEcCtD
Nalbuphine—Headache—Vinblastine—lung cancer	0.00152	0.00168	CcSEcCtD
Nalbuphine—Hypotension—Gemcitabine—lung cancer	0.00152	0.00168	CcSEcCtD
Nalbuphine—Oedema—Cisplatin—lung cancer	0.00151	0.00167	CcSEcCtD
Nalbuphine—Flushing—Docetaxel—lung cancer	0.00151	0.00166	CcSEcCtD
Nalbuphine—Vomiting—Topotecan—lung cancer	0.0015	0.00166	CcSEcCtD
Nalbuphine—Paraesthesia—Irinotecan—lung cancer	0.0015	0.00165	CcSEcCtD
Nalbuphine—Vertigo—Paclitaxel—lung cancer	0.0015	0.00165	CcSEcCtD
Nalbuphine—Syncope—Paclitaxel—lung cancer	0.00149	0.00165	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—lung cancer	0.00149	0.00165	CcSEcCtD
Nalbuphine—Naloxone—ALB—lung cancer	0.00149	0.0528	CrCbGaD
Nalbuphine—Rash—Topotecan—lung cancer	0.00149	0.00164	CcSEcCtD
Nalbuphine—Hypersensitivity—Vinorelbine—lung cancer	0.00149	0.00164	CcSEcCtD
Nalbuphine—Dermatitis—Topotecan—lung cancer	0.00149	0.00164	CcSEcCtD
Nalbuphine—Vomiting—Erlotinib—lung cancer	0.00149	0.00164	CcSEcCtD
Nalbuphine—Dyspnoea—Irinotecan—lung cancer	0.00149	0.00164	CcSEcCtD
Nalbuphine—Somnolence—Irinotecan—lung cancer	0.00148	0.00164	CcSEcCtD
Nalbuphine—Headache—Topotecan—lung cancer	0.00148	0.00163	CcSEcCtD
Nalbuphine—Tachycardia—Cisplatin—lung cancer	0.00148	0.00163	CcSEcCtD
Nalbuphine—Rash—Erlotinib—lung cancer	0.00147	0.00163	CcSEcCtD
Nalbuphine—Dermatitis—Erlotinib—lung cancer	0.00147	0.00163	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—lung cancer	0.00147	0.00163	CcSEcCtD
Nalbuphine—Dyspepsia—Irinotecan—lung cancer	0.00147	0.00162	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—lung cancer	0.00147	0.00162	CcSEcCtD
Nalbuphine—Headache—Erlotinib—lung cancer	0.00147	0.00162	CcSEcCtD
Nalbuphine—Loss of consciousness—Paclitaxel—lung cancer	0.00147	0.00162	CcSEcCtD
Nalbuphine—Hyperhidrosis—Cisplatin—lung cancer	0.00146	0.00162	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—lung cancer	0.00146	0.00161	CcSEcCtD
Nalbuphine—Paraesthesia—Gemcitabine—lung cancer	0.00146	0.00161	CcSEcCtD
Nalbuphine—Asthenia—Vinorelbine—lung cancer	0.00145	0.0016	CcSEcCtD
Nalbuphine—Dyspnoea—Gemcitabine—lung cancer	0.00145	0.0016	CcSEcCtD
Nalbuphine—Nausea—Vinblastine—lung cancer	0.00145	0.0016	CcSEcCtD
Nalbuphine—Somnolence—Gemcitabine—lung cancer	0.00144	0.00159	CcSEcCtD
Nalbuphine—Convulsion—Paclitaxel—lung cancer	0.00144	0.00159	CcSEcCtD
Nalbuphine—Hypertension—Paclitaxel—lung cancer	0.00144	0.00159	CcSEcCtD
Nalbuphine—Buprenorphine—ABCB1—lung cancer	0.00143	0.0507	CrCbGaD
Nalbuphine—Pruritus—Vinorelbine—lung cancer	0.00143	0.00158	CcSEcCtD
Nalbuphine—Naloxone—ABCB1—lung cancer	0.00142	0.0503	CrCbGaD
Nalbuphine—Hypotension—Cisplatin—lung cancer	0.00142	0.00156	CcSEcCtD
Nalbuphine—Anxiety—Paclitaxel—lung cancer	0.00141	0.00156	CcSEcCtD
Nalbuphine—Erythema—Docetaxel—lung cancer	0.00141	0.00156	CcSEcCtD
Nalbuphine—Nausea—Topotecan—lung cancer	0.0014	0.00155	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—lung cancer	0.0014	0.00154	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—lung cancer	0.00139	0.00154	CcSEcCtD
Nalbuphine—Nausea—Erlotinib—lung cancer	0.00139	0.00153	CcSEcCtD
Nalbuphine—Dry mouth—Paclitaxel—lung cancer	0.00139	0.00153	CcSEcCtD
Nalbuphine—Dysgeusia—Docetaxel—lung cancer	0.00138	0.00153	CcSEcCtD
Nalbuphine—Feeling abnormal—Irinotecan—lung cancer	0.00137	0.00152	CcSEcCtD
Nalbuphine—Confusional state—Paclitaxel—lung cancer	0.00137	0.00151	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Irinotecan—lung cancer	0.00136	0.0015	CcSEcCtD
Nalbuphine—Oedema—Paclitaxel—lung cancer	0.00136	0.0015	CcSEcCtD
Nalbuphine—Paraesthesia—Cisplatin—lung cancer	0.00136	0.0015	CcSEcCtD
Nalbuphine—Muscle spasms—Docetaxel—lung cancer	0.00136	0.0015	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—lung cancer	0.00135	0.00149	CcSEcCtD
Nalbuphine—Dyspnoea—Cisplatin—lung cancer	0.00135	0.00149	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—lung cancer	0.00134	0.00148	CcSEcCtD
Nalbuphine—Feeling abnormal—Gemcitabine—lung cancer	0.00134	0.00148	CcSEcCtD
Nalbuphine—Shock—Paclitaxel—lung cancer	0.00134	0.00148	CcSEcCtD
Nalbuphine—Dizziness—Vinorelbine—lung cancer	0.00134	0.00148	CcSEcCtD
Nalbuphine—Tachycardia—Paclitaxel—lung cancer	0.00133	0.00146	CcSEcCtD
Nalbuphine—Abdominal pain—Irinotecan—lung cancer	0.00132	0.00145	CcSEcCtD
Nalbuphine—Body temperature increased—Irinotecan—lung cancer	0.00132	0.00145	CcSEcCtD
Nalbuphine—Hyperhidrosis—Paclitaxel—lung cancer	0.00132	0.00145	CcSEcCtD
Nalbuphine—Depression—Methotrexate—lung cancer	0.0013	0.00143	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—lung cancer	0.0013	0.00143	CcSEcCtD
Nalbuphine—Vomiting—Vinorelbine—lung cancer	0.00129	0.00142	CcSEcCtD
Nalbuphine—Body temperature increased—Gemcitabine—lung cancer	0.00128	0.00142	CcSEcCtD
Nalbuphine—Rash—Vinorelbine—lung cancer	0.00128	0.00141	CcSEcCtD
Nalbuphine—Dermatitis—Vinorelbine—lung cancer	0.00127	0.00141	CcSEcCtD
Nalbuphine—Hypotension—Paclitaxel—lung cancer	0.00127	0.0014	CcSEcCtD
Nalbuphine—Headache—Vinorelbine—lung cancer	0.00127	0.0014	CcSEcCtD
Nalbuphine—Syncope—Docetaxel—lung cancer	0.00127	0.0014	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—lung cancer	0.00127	0.0014	CcSEcCtD
Nalbuphine—Feeling abnormal—Cisplatin—lung cancer	0.00125	0.00138	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—lung cancer	0.00125	0.00137	CcSEcCtD
Nalbuphine—Loss of consciousness—Docetaxel—lung cancer	0.00124	0.00137	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—lung cancer	0.00124	0.00136	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—lung cancer	0.00123	0.00136	CcSEcCtD
Nalbuphine—Hypersensitivity—Irinotecan—lung cancer	0.00123	0.00136	CcSEcCtD
Nalbuphine—Convulsion—Docetaxel—lung cancer	0.00122	0.00135	CcSEcCtD
Nalbuphine—Paraesthesia—Paclitaxel—lung cancer	0.00122	0.00135	CcSEcCtD
Nalbuphine—Hypertension—Docetaxel—lung cancer	0.00122	0.00135	CcSEcCtD
Nalbuphine—Dyspnoea—Paclitaxel—lung cancer	0.00121	0.00134	CcSEcCtD
Nalbuphine—Somnolence—Paclitaxel—lung cancer	0.00121	0.00133	CcSEcCtD
Nalbuphine—Nausea—Vinorelbine—lung cancer	0.0012	0.00133	CcSEcCtD
Nalbuphine—Morphine—ABCB1—lung cancer	0.0012	0.0425	CrCbGaD
Nalbuphine—Dyspepsia—Paclitaxel—lung cancer	0.0012	0.00132	CcSEcCtD
Nalbuphine—Body temperature increased—Cisplatin—lung cancer	0.0012	0.00132	CcSEcCtD
Nalbuphine—Asthenia—Irinotecan—lung cancer	0.0012	0.00132	CcSEcCtD
Nalbuphine—Dry mouth—Docetaxel—lung cancer	0.00118	0.0013	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—lung cancer	0.00117	0.00129	CcSEcCtD
Nalbuphine—Asthenia—Gemcitabine—lung cancer	0.00117	0.00129	CcSEcCtD
Nalbuphine—Confusional state—Docetaxel—lung cancer	0.00116	0.00128	CcSEcCtD
Nalbuphine—Oedema—Docetaxel—lung cancer	0.00115	0.00127	CcSEcCtD
Nalbuphine—Pruritus—Gemcitabine—lung cancer	0.00115	0.00127	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—lung cancer	0.00114	0.00126	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—lung cancer	0.00113	0.00125	CcSEcCtD
Nalbuphine—Shock—Docetaxel—lung cancer	0.00113	0.00125	CcSEcCtD
Nalbuphine—Tachycardia—Docetaxel—lung cancer	0.00113	0.00124	CcSEcCtD
Nalbuphine—Feeling abnormal—Paclitaxel—lung cancer	0.00112	0.00124	CcSEcCtD
Nalbuphine—Hypersensitivity—Cisplatin—lung cancer	0.00112	0.00123	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Paclitaxel—lung cancer	0.00111	0.00123	CcSEcCtD
Nalbuphine—Dizziness—Irinotecan—lung cancer	0.0011	0.00122	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—lung cancer	0.0011	0.00122	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—lung cancer	0.0011	0.00121	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—lung cancer	0.0011	0.00121	CcSEcCtD
Nalbuphine—Asthenia—Cisplatin—lung cancer	0.00109	0.0012	CcSEcCtD
Nalbuphine—Urticaria—Paclitaxel—lung cancer	0.00108	0.00119	CcSEcCtD
Nalbuphine—Hypotension—Docetaxel—lung cancer	0.00108	0.00119	CcSEcCtD
Nalbuphine—Abdominal pain—Paclitaxel—lung cancer	0.00108	0.00119	CcSEcCtD
Nalbuphine—Body temperature increased—Paclitaxel—lung cancer	0.00108	0.00119	CcSEcCtD
Nalbuphine—Vomiting—Irinotecan—lung cancer	0.00106	0.00117	CcSEcCtD
Nalbuphine—Rash—Irinotecan—lung cancer	0.00105	0.00116	CcSEcCtD
Nalbuphine—Dermatitis—Irinotecan—lung cancer	0.00105	0.00116	CcSEcCtD
Nalbuphine—Headache—Irinotecan—lung cancer	0.00105	0.00115	CcSEcCtD
Nalbuphine—Paraesthesia—Docetaxel—lung cancer	0.00104	0.00114	CcSEcCtD
Nalbuphine—Vomiting—Gemcitabine—lung cancer	0.00103	0.00114	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—lung cancer	0.00103	0.00114	CcSEcCtD
Nalbuphine—Dyspnoea—Docetaxel—lung cancer	0.00103	0.00113	CcSEcCtD
Nalbuphine—Somnolence—Docetaxel—lung cancer	0.00103	0.00113	CcSEcCtD
Nalbuphine—Rash—Gemcitabine—lung cancer	0.00102	0.00113	CcSEcCtD
Nalbuphine—Dermatitis—Gemcitabine—lung cancer	0.00102	0.00113	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—lung cancer	0.00102	0.00113	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—lung cancer	0.00102	0.00112	CcSEcCtD
Nalbuphine—Headache—Gemcitabine—lung cancer	0.00102	0.00112	CcSEcCtD
Nalbuphine—Dyspepsia—Docetaxel—lung cancer	0.00102	0.00112	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—lung cancer	0.00101	0.00111	CcSEcCtD
Nalbuphine—Hypersensitivity—Paclitaxel—lung cancer	0.001	0.00111	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—lung cancer	0.000997	0.0011	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—lung cancer	0.000996	0.0011	CcSEcCtD
Nalbuphine—Nausea—Irinotecan—lung cancer	0.000991	0.00109	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—lung cancer	0.000982	0.00108	CcSEcCtD
Nalbuphine—Asthenia—Paclitaxel—lung cancer	0.000976	0.00108	CcSEcCtD
Nalbuphine—Nausea—Gemcitabine—lung cancer	0.000965	0.00106	CcSEcCtD
Nalbuphine—Vomiting—Cisplatin—lung cancer	0.000963	0.00106	CcSEcCtD
Nalbuphine—Pruritus—Paclitaxel—lung cancer	0.000963	0.00106	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—lung cancer	0.00096	0.00106	CcSEcCtD
Nalbuphine—Rash—Cisplatin—lung cancer	0.000955	0.00105	CcSEcCtD
Nalbuphine—Dermatitis—Cisplatin—lung cancer	0.000954	0.00105	CcSEcCtD
Nalbuphine—Feeling abnormal—Docetaxel—lung cancer	0.00095	0.00105	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Docetaxel—lung cancer	0.000943	0.00104	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—lung cancer	0.00094	0.00104	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—lung cancer	0.000918	0.00101	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—lung cancer	0.000915	0.00101	CcSEcCtD
Nalbuphine—Body temperature increased—Docetaxel—lung cancer	0.000912	0.00101	CcSEcCtD
Nalbuphine—Abdominal pain—Docetaxel—lung cancer	0.000912	0.00101	CcSEcCtD
Nalbuphine—Dizziness—Paclitaxel—lung cancer	0.0009	0.000993	CcSEcCtD
Nalbuphine—Nausea—Cisplatin—lung cancer	0.0009	0.000993	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—lung cancer	0.000882	0.000973	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—lung cancer	0.000882	0.000973	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—lung cancer	0.000882	0.000973	CcSEcCtD
Nalbuphine—Rash—Etoposide—lung cancer	0.000875	0.000965	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—lung cancer	0.000874	0.000964	CcSEcCtD
Nalbuphine—Headache—Etoposide—lung cancer	0.000869	0.000959	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—lung cancer	0.000865	0.000955	CcSEcCtD
Nalbuphine—Vomiting—Paclitaxel—lung cancer	0.000865	0.000954	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—lung cancer	0.000864	0.000953	CcSEcCtD
Nalbuphine—Rash—Paclitaxel—lung cancer	0.000858	0.000946	CcSEcCtD
Nalbuphine—Dermatitis—Paclitaxel—lung cancer	0.000857	0.000946	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—lung cancer	0.000856	0.000945	CcSEcCtD
Nalbuphine—Headache—Paclitaxel—lung cancer	0.000852	0.00094	CcSEcCtD
Nalbuphine—Hypersensitivity—Docetaxel—lung cancer	0.00085	0.000937	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—lung cancer	0.000848	0.000935	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—lung cancer	0.000838	0.000925	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—lung cancer	0.000831	0.000917	CcSEcCtD
Nalbuphine—Asthenia—Docetaxel—lung cancer	0.000827	0.000913	CcSEcCtD
Nalbuphine—Nausea—Etoposide—lung cancer	0.000824	0.000909	CcSEcCtD
Nalbuphine—Pruritus—Docetaxel—lung cancer	0.000816	0.0009	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—lung cancer	0.00081	0.000894	CcSEcCtD
Nalbuphine—Nausea—Paclitaxel—lung cancer	0.000808	0.000892	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—lung cancer	0.000803	0.000886	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—lung cancer	0.000792	0.000874	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—lung cancer	0.000791	0.000872	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—lung cancer	0.000777	0.000857	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—lung cancer	0.000775	0.000855	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—lung cancer	0.000764	0.000843	CcSEcCtD
Nalbuphine—Dizziness—Docetaxel—lung cancer	0.000763	0.000841	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—lung cancer	0.000761	0.00084	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—lung cancer	0.000748	0.000825	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—lung cancer	0.000746	0.000823	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—lung cancer	0.000741	0.000818	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—lung cancer	0.000739	0.000815	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—lung cancer	0.000734	0.00081	CcSEcCtD
Nalbuphine—Vomiting—Docetaxel—lung cancer	0.000733	0.000809	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—lung cancer	0.000732	0.000807	CcSEcCtD
Nalbuphine—Rash—Docetaxel—lung cancer	0.000727	0.000802	CcSEcCtD
Nalbuphine—Dermatitis—Docetaxel—lung cancer	0.000726	0.000801	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—lung cancer	0.000726	0.000801	CcSEcCtD
Nalbuphine—Headache—Docetaxel—lung cancer	0.000722	0.000797	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—lung cancer	0.00072	0.000794	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—lung cancer	0.000708	0.000781	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—lung cancer	0.000702	0.000775	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—lung cancer	0.000696	0.000768	CcSEcCtD
Nalbuphine—Nausea—Docetaxel—lung cancer	0.000685	0.000756	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—lung cancer	0.000685	0.000756	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—lung cancer	0.00068	0.00075	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—lung cancer	0.000672	0.000742	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—lung cancer	0.00066	0.000728	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—lung cancer	0.000657	0.000725	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—lung cancer	0.000657	0.000725	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—lung cancer	0.000646	0.000713	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—lung cancer	0.000642	0.000708	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—lung cancer	0.00064	0.000706	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—lung cancer	0.000633	0.000699	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—lung cancer	0.000612	0.000676	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—lung cancer	0.000596	0.000658	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—lung cancer	0.000593	0.000654	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000588	0.000649	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—lung cancer	0.000588	0.000649	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—lung cancer	0.000572	0.000631	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—lung cancer	0.000569	0.000628	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—lung cancer	0.000569	0.000628	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—lung cancer	0.00055	0.000606	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—lung cancer	0.00053	0.000585	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—lung cancer	0.000528	0.000583	CcSEcCtD
Nalbuphine—Rash—Methotrexate—lung cancer	0.000524	0.000578	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—lung cancer	0.000524	0.000578	CcSEcCtD
Nalbuphine—Headache—Methotrexate—lung cancer	0.000521	0.000574	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—lung cancer	0.000516	0.00057	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—lung cancer	0.000509	0.000562	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—lung cancer	0.000494	0.000545	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—lung cancer	0.000476	0.000525	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—lung cancer	0.000458	0.000505	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—lung cancer	0.000454	0.000501	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—lung cancer	0.000453	0.0005	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—lung cancer	0.000451	0.000497	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—lung cancer	0.000427	0.000472	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—ANXA1—lung cancer	7.39e-05	0.00113	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PPP2R1B—lung cancer	7.23e-05	0.00111	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SMARCA4—lung cancer	7.23e-05	0.00111	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FLT1—lung cancer	7.16e-05	0.00109	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CG—lung cancer	7.09e-05	0.00108	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APP—lung cancer	7.01e-05	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH3—lung cancer	7.01e-05	0.00107	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HSPB1—lung cancer	6.97e-05	0.00107	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNG11—lung cancer	6.97e-05	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGF9—lung cancer	6.95e-05	0.00106	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTHLH—lung cancer	6.89e-05	0.00105	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL8—lung cancer	6.85e-05	0.00105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AVP—lung cancer	6.84e-05	0.00105	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—POMC—lung cancer	6.75e-05	0.00103	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFC—lung cancer	6.64e-05	0.00101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JUNB—lung cancer	6.63e-05	0.00101	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ANXA1—lung cancer	6.48e-05	0.000991	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CG—lung cancer	6.44e-05	0.000985	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FLT1—lung cancer	6.28e-05	0.00096	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADCY1—lung cancer	6.27e-05	0.000958	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CD—lung cancer	6.23e-05	0.000953	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CG—lung cancer	6.22e-05	0.000951	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APP—lung cancer	6.14e-05	0.00094	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH3—lung cancer	6.14e-05	0.00094	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—POMC—lung cancer	6.13e-05	0.000937	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PPP2R1B—lung cancer	6.11e-05	0.000934	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SMARCA4—lung cancer	6.11e-05	0.000934	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF9—lung cancer	6.09e-05	0.000932	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STK11—lung cancer	6.02e-05	0.000921	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6R—lung cancer	5.98e-05	0.000914	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—POMC—lung cancer	5.92e-05	0.000905	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HSPB1—lung cancer	5.89e-05	0.000901	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTHLH—lung cancer	5.83e-05	0.000891	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JUNB—lung cancer	5.82e-05	0.00089	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FOXO3—lung cancer	5.81e-05	0.000889	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAP2K1—lung cancer	5.7e-05	0.000872	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CD—lung cancer	5.66e-05	0.000866	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CG—lung cancer	5.65e-05	0.000864	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ANXA1—lung cancer	5.48e-05	0.000838	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CD—lung cancer	5.47e-05	0.000836	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AVP—lung cancer	5.45e-05	0.000833	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CB—lung cancer	5.43e-05	0.000831	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—POMC—lung cancer	5.37e-05	0.000822	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FLT1—lung cancer	5.3e-05	0.000811	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STK11—lung cancer	5.28e-05	0.000808	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CG—lung cancer	5.25e-05	0.000804	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1R—lung cancer	5.24e-05	0.000802	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6R—lung cancer	5.24e-05	0.000802	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—lung cancer	5.22e-05	0.000799	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH3—lung cancer	5.19e-05	0.000794	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APP—lung cancer	5.19e-05	0.000794	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HES1—lung cancer	5.15e-05	0.000788	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF9—lung cancer	5.15e-05	0.000788	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FOXO3—lung cancer	5.1e-05	0.00078	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—RAF1—lung cancer	5.05e-05	0.000773	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—POMC—lung cancer	5e-05	0.000765	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAP2K1—lung cancer	5e-05	0.000764	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2—lung cancer	4.99e-05	0.000763	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CD—lung cancer	4.96e-05	0.000759	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CB—lung cancer	4.93e-05	0.000755	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JUNB—lung cancer	4.92e-05	0.000752	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AVP—lung cancer	4.78e-05	0.000731	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—lung cancer	4.77e-05	0.00073	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CB—lung cancer	4.76e-05	0.000729	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—lung cancer	4.74e-05	0.000725	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB3—lung cancer	4.71e-05	0.00072	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CD—lung cancer	4.62e-05	0.000707	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1R—lung cancer	4.6e-05	0.000703	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—lung cancer	4.58e-05	0.0007	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—POMC—lung cancer	4.54e-05	0.000695	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—lung cancer	4.53e-05	0.000693	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HES1—lung cancer	4.52e-05	0.000691	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TERT—lung cancer	4.51e-05	0.000691	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STK11—lung cancer	4.46e-05	0.000683	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—RAF1—lung cancer	4.43e-05	0.000678	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6R—lung cancer	4.43e-05	0.000678	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGFR1—lung cancer	4.38e-05	0.00067	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—lung cancer	4.38e-05	0.000669	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CB—lung cancer	4.33e-05	0.000662	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HIF1A—lung cancer	4.32e-05	0.00066	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FOXO3—lung cancer	4.31e-05	0.000659	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAP2K1—lung cancer	4.22e-05	0.000646	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CD—lung cancer	4.19e-05	0.000642	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOA1—lung cancer	4.17e-05	0.000637	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—lung cancer	4.16e-05	0.000636	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB3—lung cancer	4.13e-05	0.000632	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KDR—lung cancer	4.13e-05	0.000632	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AVP—lung cancer	4.04e-05	0.000618	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	4.03e-05	0.000616	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—lung cancer	3.97e-05	0.000608	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TERT—lung cancer	3.96e-05	0.000605	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1R—lung cancer	3.89e-05	0.000594	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	3.87e-05	0.000592	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGFR1—lung cancer	3.84e-05	0.000588	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HES1—lung cancer	3.82e-05	0.000584	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—lung cancer	3.8e-05	0.000582	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KIT—lung cancer	3.8e-05	0.000582	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APC—lung cancer	3.8e-05	0.000582	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—NRAS—lung cancer	3.8e-05	0.000582	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HIF1A—lung cancer	3.79e-05	0.000579	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGF—lung cancer	3.76e-05	0.000575	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RAF1—lung cancer	3.75e-05	0.000573	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—lung cancer	3.7e-05	0.000566	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	3.66e-05	0.000559	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOA1—lung cancer	3.65e-05	0.000559	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK3—lung cancer	3.64e-05	0.000557	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—POMC—lung cancer	3.62e-05	0.000554	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KDR—lung cancer	3.62e-05	0.000554	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BRAF—lung cancer	3.58e-05	0.000547	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6R—lung cancer	3.53e-05	0.00054	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CREBBP—lung cancer	3.53e-05	0.000539	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—lung cancer	3.51e-05	0.000537	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB3—lung cancer	3.49e-05	0.000534	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—lung cancer	3.47e-05	0.00053	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAP2K1—lung cancer	3.37e-05	0.000515	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—lung cancer	3.36e-05	0.000514	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TERT—lung cancer	3.35e-05	0.000512	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CD—lung cancer	3.34e-05	0.000511	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KIT—lung cancer	3.34e-05	0.00051	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APC—lung cancer	3.34e-05	0.00051	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—lung cancer	3.34e-05	0.00051	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—NRAS—lung cancer	3.34e-05	0.00051	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	3.31e-05	0.000507	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGF—lung cancer	3.3e-05	0.000504	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KRAS—lung cancer	3.27e-05	0.000501	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGFR1—lung cancer	3.25e-05	0.000497	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HIF1A—lung cancer	3.2e-05	0.000489	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK3—lung cancer	3.19e-05	0.000489	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—POMC—lung cancer	3.17e-05	0.000486	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BRAF—lung cancer	3.14e-05	0.00048	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6R—lung cancer	3.1e-05	0.000474	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CREBBP—lung cancer	3.09e-05	0.000473	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOA1—lung cancer	3.09e-05	0.000472	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KDR—lung cancer	3.06e-05	0.000468	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—lung cancer	3.04e-05	0.000465	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	3.01e-05	0.00046	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MDM2—lung cancer	3e-05	0.000458	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RAF1—lung cancer	2.99e-05	0.000457	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB2—lung cancer	2.95e-05	0.000452	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAP2K1—lung cancer	2.95e-05	0.000451	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CD—lung cancer	2.93e-05	0.000448	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CB—lung cancer	2.91e-05	0.000446	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MTOR—lung cancer	2.91e-05	0.000446	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	2.9e-05	0.000444	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KRAS—lung cancer	2.87e-05	0.000439	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APC—lung cancer	2.82e-05	0.000431	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KIT—lung cancer	2.82e-05	0.000431	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—lung cancer	2.82e-05	0.000431	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—NRAS—lung cancer	2.82e-05	0.000431	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—lung cancer	2.8e-05	0.000428	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGF—lung cancer	2.79e-05	0.000426	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HRAS—lung cancer	2.78e-05	0.000426	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—lung cancer	2.71e-05	0.000414	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK3—lung cancer	2.7e-05	0.000413	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—POMC—lung cancer	2.68e-05	0.00041	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—lung cancer	2.68e-05	0.00041	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—lung cancer	2.68e-05	0.000409	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—lung cancer	2.66e-05	0.000407	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BRAF—lung cancer	2.65e-05	0.000405	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	2.64e-05	0.000403	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MDM2—lung cancer	2.63e-05	0.000402	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RAF1—lung cancer	2.62e-05	0.0004	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6R—lung cancer	2.62e-05	0.0004	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CREBBP—lung cancer	2.61e-05	0.0004	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCND1—lung cancer	2.61e-05	0.000399	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JUN—lung cancer	2.6e-05	0.000398	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB2—lung cancer	2.59e-05	0.000396	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—lung cancer	2.57e-05	0.000393	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CB—lung cancer	2.56e-05	0.000391	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MTOR—lung cancer	2.56e-05	0.000391	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—lung cancer	2.53e-05	0.000387	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1A—lung cancer	2.52e-05	0.000386	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTEN—lung cancer	2.52e-05	0.000385	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAP2K1—lung cancer	2.49e-05	0.000382	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CD—lung cancer	2.48e-05	0.000379	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—lung cancer	2.46e-05	0.000376	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—lung cancer	2.46e-05	0.000376	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	2.45e-05	0.000375	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HRAS—lung cancer	2.44e-05	0.000373	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KRAS—lung cancer	2.43e-05	0.000371	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EP300—lung cancer	2.4e-05	0.000367	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—lung cancer	2.37e-05	0.000363	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—lung cancer	2.35e-05	0.00036	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—lung cancer	2.35e-05	0.000359	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SRC—lung cancer	2.34e-05	0.000357	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—lung cancer	2.34e-05	0.000357	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCND1—lung cancer	2.29e-05	0.00035	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JUN—lung cancer	2.28e-05	0.000349	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—lung cancer	2.27e-05	0.000348	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—lung cancer	2.25e-05	0.000345	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NRAS—lung cancer	2.25e-05	0.000344	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	2.23e-05	0.000341	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—lung cancer	2.22e-05	0.00034	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MDM2—lung cancer	2.22e-05	0.00034	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1A—lung cancer	2.21e-05	0.000339	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RAF1—lung cancer	2.21e-05	0.000338	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTEN—lung cancer	2.21e-05	0.000338	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB2—lung cancer	2.19e-05	0.000335	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CB—lung cancer	2.16e-05	0.00033	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MTOR—lung cancer	2.16e-05	0.00033	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—lung cancer	2.15e-05	0.00033	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK3—lung cancer	2.15e-05	0.000329	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EP300—lung cancer	2.11e-05	0.000322	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—lung cancer	2.09e-05	0.00032	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—lung cancer	2.08e-05	0.000317	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HRAS—lung cancer	2.06e-05	0.000315	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SRC—lung cancer	2.05e-05	0.000313	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—lung cancer	2.05e-05	0.000313	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—lung cancer	2.01e-05	0.000307	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—lung cancer	1.99e-05	0.000305	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—lung cancer	1.99e-05	0.000304	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—lung cancer	1.98e-05	0.000303	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—lung cancer	1.98e-05	0.000302	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—lung cancer	1.97e-05	0.000302	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NRAS—lung cancer	1.97e-05	0.000301	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KRAS—lung cancer	1.93e-05	0.000296	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCND1—lung cancer	1.93e-05	0.000296	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JUN—lung cancer	1.93e-05	0.000295	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK3—lung cancer	1.89e-05	0.000289	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—lung cancer	1.88e-05	0.000287	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1A—lung cancer	1.87e-05	0.000286	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTEN—lung cancer	1.87e-05	0.000285	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—lung cancer	1.84e-05	0.000281	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—lung cancer	1.82e-05	0.000279	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—lung cancer	1.8e-05	0.000275	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EP300—lung cancer	1.78e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—lung cancer	1.78e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SRC—lung cancer	1.73e-05	0.000265	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—lung cancer	1.72e-05	0.000263	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KRAS—lung cancer	1.7e-05	0.000259	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—lung cancer	1.69e-05	0.000258	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—lung cancer	1.67e-05	0.000255	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NRAS—lung cancer	1.67e-05	0.000255	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HRAS—lung cancer	1.64e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.59e-05	0.000244	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—lung cancer	1.57e-05	0.000241	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.56e-05	0.000238	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—lung cancer	1.55e-05	0.000237	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—lung cancer	1.52e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—lung cancer	1.51e-05	0.000231	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—lung cancer	1.45e-05	0.000222	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HRAS—lung cancer	1.44e-05	0.00022	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KRAS—lung cancer	1.43e-05	0.000219	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—lung cancer	1.38e-05	0.000211	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—lung cancer	1.32e-05	0.000201	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—lung cancer	1.27e-05	0.000195	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—lung cancer	1.27e-05	0.000195	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HRAS—lung cancer	1.22e-05	0.000186	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—lung cancer	1.17e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—lung cancer	1.08e-05	0.000165	CbGpPWpGaD
